Skip to main content
. 2010 Jan 20;2010(1):CD006605. doi: 10.1002/14651858.CD006605.pub2

Anderson 1999.

Methods Case series
 Duration: 24 months
Participants N = 30 enrolled
 Primary condition: Most had back and/or leg pain, In 47% associated with failed back surgery syndrome
 Baseline pain score: Mean 78.5 (SD 15.9, Range 39 to 100)/100 VAS
 Time since onset: 8 years (SD 9 years, Range 5 to 24 years)
 Mean age: 58 years (SD 13 years)
 Female: 53%
Previous opioid analgesia: All patients had taken systemic narcotics before study enrolment, and 28/30 (93%) were taking them regularly at time of enrolment
Interventions Intrathecal morphine
Initial dose: Mean 1 mg/day
Titration up to 25 mg/day at endpoint
Supplemental analgesia: Allowed. At 24 months, 6/20 (30%) patients used supplemental oral narcotics
Outcomes Discontinuation due to adverse events
 Adverse events
 Discontinuation due to insufficient pain relief
 Pain (continuous) and pain relief (proportion with at least 50% relief)
Function
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Comparability of patients at baseline and follow‐up (continuous data) 
 All outcomes High risk Due to attrition
Selection method random or consecutive Low risk Consecutive
Prospective Low risk Prospective
Free from confounding treatment(s) High risk Supplemental analgesia allowed
Patient compliance monitored and reported at at least 85%? Low risk Pump administration
Attrition and right censoring less than 15% (continuous data) 
 All outcomes High risk Higher attrition
Funding from a source without financial conflict of interest? High risk Funding from Medtronic